Riociguat (BAY 63-2521, trade name Adempas) is a novel drug (by Bayer) that is a stimulator of soluble guanylate cyclase (sGC).
Riociguat (BAY 63) is a novel drug (by Bayer). This novel drug (by Bayer) is a stimulator of soluble guanylate cyclase (sGC). BAY 63 is 2521. Trade name Adempas are 2521.